Time to clozapine response in a standardized trial.
Time to clozapine response in a standardized trial.
复制标题
标准化试验中氯氮平反应的时间。
DOI:
10.1176/ajp.154.9.1243
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
Tamminga,CA
中科院分区:
文献类型:
--
作者:
Conley,RR;CarpenterJr,WT;Tamminga,CA
ObjectiveThe authors sought to determine the time to clozapine response in treatment-refractory patients with schizophrenia.MethodAntipsychotic response to a clozapine trial was examined in 50 treatment-refractory schizophrenic inpatients. Subjects were treated with clozapine for at least 12 months, regardless of response status, according to a standardized, increasing dose protocol. Behavioral changes were measured through monthly assessments with the Brief Psychiatric Rating Scale.ResultsThirty-four subjects (68%) met clinical response criteria by the end of the trial. Response was achieved at a mean dose of 468 mg/day (SD= 168). The dose of 30 (88%) of the responding patients was 600 mg/day or less. The mean time to response was 82 days (SD= 100, range= 10–401). It took an average of 60 days (SD= 87) for subjects to reach the dose at which clozapine response was achieved. Once this dose was reached, the average response time was 17 days (SD= 14, range= 2–56). All 34 subjects who responded met criteria within 8 weeks of a clozapine dose escalation. No late response was found in the remaining 16 subjects despite a mean follow-up period of 75 weeks (SD= 50).ConclusionsIn this study, all patients who responded to clozapine did so within 8 weeks of a change in dose. Thus, there appears to be little clinical gain in prolonging exposure to clozapine beyond 8 weeks at any particular dose if no response is seen.